LINK WILLIAM J PHD
Insider CIK 1228684 · EW Director · RXST Director, 10% owner · GKOS Director, 10% owner · EYES Director, 10% owner · INGN Director, 10% owner · LNSR Director · FLXN Director, 10% owner · PZRX 10% owner · OYST Director, 10% owner · TARS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 605 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 106,987 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 11,675 | $78.33 | $914.5K | 95,312 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 759 | $79.00 | $60.0K | 94,553 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 66 | $80.01 | $5.3K | 94,487 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 605 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 66 | $80.01 | $5.3K | 94,487 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 759 | $79.00 | $60.0K | 94,553 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-15 | 2026-09-17 | 11,675 | $78.33 | $914.5K | 95,312 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-09-15 | 2026-09-17 | 201 | — | — | 106,987 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 806 | — | $0 | 806 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 2,417 | — | $0 | 2,417 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 3,837 | — | $0 | 3,837 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2026-06-17 | 2026-06-18 | 37,037 | — | $0 | 74,892 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-06-15 | 2026-06-17 | 1,928 | $62.94 | $121.3K | 106,786 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-06-15 | 2026-06-17 | 10,572 | $61.97 | $655.1K | 108,714 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-06-12 | 2026-06-16 | 2,954 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-06-12 | 2026-06-16 | 2,954 | — | $0 | 119,286 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2026-06-03 | 2026-06-05 | 17,421 | — | $0 | 568,062 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-16 | 2026-03-18 | 3,629 | $68.09 | $247.1K | 125,203 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-16 | 2026-03-18 | 493 | $69.75 | $34.4K | 116,332 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-16 | 2026-03-18 | 8,378 | $69.03 | $578.3K | 116,825 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-15 | 2025-12-17 | 6,306 | $81.75 | $515.5K | 129,980 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-15 | 2025-12-17 | 4,766 | $81.50 | $388.4K | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-15 | 2025-12-17 | 5,680 | $80.71 | $458.4K | 4,766 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-15 | 2025-12-17 | 1,148 | $82.39 | $94.6K | 128,832 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-15 | 2025-12-17 | 5,046 | $80.80 | $407.7K | 136,286 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | G Gift | 2025-09-16 | 2025-09-18 | 2,000 | — | $0 | 141,332 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-09-08 | 2025-09-10 | 27,116 | $57.00 | $1.55M | 143,332 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-06-13 | 2025-06-16 | 3,350 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-06-13 | 2025-06-16 | 3,350 | — | $0 | 170,448 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 2,954 | — | $0 | 2,954 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 4,540 | — | $0 | 4,540 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2025-06-03 | 2025-06-04 | 10,752 | — | $0 | 37,855 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2025-05-23 | 2025-05-28 | 7,374 | — | $0 | 550,641 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2024-08-12 | 2024-08-14 | 27,116 | — | $0 | 167,098 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2024-08-12 | 2024-08-14 | 74,892 | — | $0 | 35,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2024-08-12 | 2024-08-14 | 10,446 | — | $0 | 10,446 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-08-12 | 2024-08-14 | 5,021 | $26.53 | $133.2K | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-08-12 | 2024-08-14 | 29,979 | $26.01 | $779.8K | 5,021 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 139,982 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 3,350 | — | $0 | 3,350 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2024-06-06 | 2024-06-10 | 2,554 | — | $0 | 27,103 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2024-05-07 | 2024-05-09 | 22,000 | — | $0 | 543,267 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 20,598 | $49.54 | $1.02M | 31,900 | SEC↗ |
| RXST RxSight, Inc. | G Gift | 2024-02-01 | 2024-02-02 | 3,000 | — | $0 | 21,248 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 7,652 | $50.01 | $382.7K | 24,248 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-17 | 2023-08-18 | 694,124 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-17 | 2023-08-18 | 2,610 | — | $0 | 24,549 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-17 | 2023-08-18 | 21,248 | — | $0 | 52,498 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 3,350 | — | $0 | 3,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 136,632 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2023-06-01 | 2023-06-05 | 5,731 | — | $0 | 21,939 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 33,175 | — | $0 | 33,175 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2023-05-25 | 2023-05-30 | 9,288 | — | $0 | 521,267 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-05-11 | 2023-05-12 | 258,390 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-05-11 | 2023-05-12 | 98,715 | — | $0 | 694,124 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2023-05-11 | 2023-05-15 | 41,219 | — | $0 | 109,892 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2023-05-11 | 2023-05-15 | 215,576 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2023-03-15 | 2023-03-17 | 52,194 | — | $0 | 68,673 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2023-03-15 | 2023-03-17 | 215,575 | — | $0 | 215,576 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2022-11-10 | 2022-11-14 | 8,382 | — | $0 | 16,479 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2022-11-10 | 2022-11-14 | 215,575 | — | $0 | 431,151 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-11-09 | 2022-11-14 | 316,694 | — | $0 | 258,390 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-11-09 | 2022-11-14 | 107,236 | — | $0 | 595,409 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2022-08-15 | 2022-08-17 | 215,575 | — | $0 | 646,726 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2022-08-15 | 2022-08-17 | 3,749 | — | $0 | 8,097 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-08-10 | 2022-08-11 | 107,236 | — | $0 | 488,173 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-08-10 | 2022-08-11 | 316,694 | — | $0 | 575,084 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 7,000 | — | $0 | 7,000 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-06-08 | 2022-06-09 | 375,000 | — | $0 | 891,778 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-06-08 | 2022-06-09 | 126,979 | — | $0 | 380,937 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2022-06-02 | 2022-06-03 | 10,349 | — | $0 | 47,458 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2022-05-25 | 2022-05-31 | 15,616 | — | $0 | 15,616 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2022-05-25 | 2022-05-31 | 4,285 | — | $0 | 511,979 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-05-17 | 2022-05-19 | 375,000 | — | $0 | 1,266,778 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-05-17 | 2022-06-08 | 126,979 | — | $0 | 253,958 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-03-15 | 2022-06-08 | 126,979 | — | $0 | 126,979 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2022-03-15 | 2022-03-17 | 375,000 | — | $0 | 1,641,778 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 401 | — | $0 | 2,074 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 6,438 | — | $0 | 33,480 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 6,438 | — | $0 | 27,042 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 400 | — | $0 | 1,673 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2021-11-11 | 2021-11-16 | 250,000 | — | $0 | 862,301 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | J Other | 2021-11-11 | 2021-11-16 | 4,348 | — | $0 | 4,348 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,531 | $15.09 | $23.1K | 4,987 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 303,614 | $14.63 | $4.44M | 1,057,976 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 242,943 | $15.09 | $3.67M | 815,033 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,912 | $14.63 | $28.0K | 6,518 | SEC↗ |
| RXST RxSight, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,016,778 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 2,016,778 | — | $0 | 2,016,778 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 31,250 | $16.00 | $500.0K | 37,109 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2021-07-30 | 2021-08-02 | 5,859 | — | $0 | 5,859 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 5,199 | — | $0 | 5,199 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2021-06-07 | 2021-06-09 | 3,466 | — | $0 | 10,066 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2021-06-03 | 2021-06-07 | 2,382 | — | $0 | 17,821 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2021-05-18 | 2021-05-20 | 20,847 | — | $0 | 20,847 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 642 | — | $0 | 1,273 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 10,302 | — | $0 | 20,604 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 631 | — | $0 | 631 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 10,302 | — | $0 | 10,302 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2020-12-10 | 2020-12-14 | 955,392 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2020-12-10 | 2020-12-14 | 27,942 | — | $0 | 27,942 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2020-12-07 | 2020-12-10 | 80,157 | — | $0 | 507,694 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2020-12-01 | 2020-12-03 | 25,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2020-12-01 | 2020-12-03 | 15,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2020-12-01 | 2020-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2020-12-01 | 2020-12-03 | 15,000 | $24.69 | $370.4K | 65,439 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2020-12-01 | 2020-12-03 | 49,400 | $67.96 | $3.36M | 16,039 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2020-12-01 | 2020-12-03 | 600 | $68.72 | $41.2K | 15,439 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2020-12-01 | 2020-12-03 | 25,000 | $32.00 | $800.0K | 50,439 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2020-12-01 | 2020-12-03 | 10,000 | $7.28 | $72.8K | 25,439 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,112,301 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 1,112,301 | — | $0 | 1,112,301 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2020-06-08 | 2020-06-10 | 6,600 | — | $0 | 6,600 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2020-06-03 | 2020-06-05 | 3,900 | — | $0 | 15,439 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2020-05-08 | 2020-05-11 | 345 | — | $0 | 11,349 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2020-05-08 | 2020-05-11 | 1,101 | — | $0 | 11,004 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2020-01-02 | 2020-01-03 | 2,113 | — | $0 | 11,539 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 1,654,359 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 955,392 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 10,420 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 1,654,359 | — | $0 | 1,974,798 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 10,420 | — | $0 | 12,438 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 27,500 | $16.00 | $440.0K | 2,002,298 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 955,392 | — | $0 | 955,392 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2019-08-21 | 2019-08-21 | 6,914 | $221.56 | $1.53M | 9,903 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2019-08-21 | 2019-08-21 | 1,650 | $222.02 | $366.3K | 4,722 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2019-08-20 | 2019-08-21 | 1,650 | $222.98 | $367.9K | 16,817 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2019-06-04 | 2019-06-05 | 56,685 | — | $0 | 56,685 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2019-05-30 | 2019-05-31 | 2,653 | — | $0 | 9,426 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2019-05-09 | 2019-05-13 | 414 | — | $0 | 18,467 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2019-05-09 | 2019-05-13 | 1,323 | — | $0 | 18,053 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2019-01-02 | 2019-01-16 | 2,140 | — | $0 | 6,773 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2018-11-19 | 2018-11-20 | 2,628 | $150.06 | $394.4K | 6,372 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2018-11-19 | 2018-11-20 | 10,950 | $149.88 | $1.64M | 6,050 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-11-15 | 2018-11-15 | 25,725 | $57.37 | $1.48M | 41,779 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-11-15 | 2018-11-15 | 1,300 | $58.18 | $75.6K | 40,479 | SEC↗ |
| GKOS GLAUKOS Corp | G Gift | 2018-11-14 | 2018-11-15 | 8,500 | — | $0 | 67,504 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-11-13 | 2018-11-15 | 14,475 | $58.01 | $839.7K | 76,004 | SEC↗ |
| EW Edwards Lifesciences Corp | G Gift | 2018-08-31 | 2018-11-20 | 10,000 | — | $0 | 17,000 | SEC↗ |
| EW Edwards Lifesciences Corp | G Gift | 2018-08-31 | 2018-11-20 | 10,000 | — | $0 | 16,730 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2018-06-02 | 2018-06-05 | 25,970 | — | $0 | 25,970 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award | 2018-06-01 | 2018-06-05 | 34,518 | — | $0 | 115,186 | SEC↗ |
| GKOS GLAUKOS Corp | A Award | 2018-05-31 | 2018-06-01 | 4,633 | — | $0 | 4,633 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2018-05-18 | 2018-05-22 | 1,655 | — | $0 | 26,251 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2018-05-18 | 2018-05-22 | 479 | — | $0 | 26,730 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2018-02-09 | 2018-02-13 | 3,600 | $122.61 | $441.4K | 24,400 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2018-02-09 | 2018-02-13 | 8,400 | $122.08 | $1.03M | 16,000 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2017-12-13 | 2017-12-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award | 2017-06-01 | 2017-06-05 | 58,021 | $1.17 | $67.9K | 80,668 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2017-05-12 | 2017-05-15 | 2,034 | — | $0 | 24,008 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2017-05-12 | 2017-05-15 | 588 | — | $0 | 24,596 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2017-03-07 | 2017-03-08 | 2,655 | — | $0 | 90,479 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2017-03-06 | 2017-03-08 | 129 | — | $0 | 87,824 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2016-11-29 | 2016-12-01 | 15,000 | $84.01 | $1.26M | 28,000 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-11-17 | 2016-11-18 | 30,000 | $33.78 | $1.01M | 87,695 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-08-16 | 2016-08-16 | 45,004 | — | $0 | 117,695 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-08-15 | 2016-08-16 | 2,195 | — | $0 | 72,691 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-08-03 | 2016-08-03 | 48,240 | — | $0 | 70,496 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-08-02 | 2016-08-03 | 2,358 | — | $0 | 22,256 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 710,091 | $14.00 | $9.94M | 3,511,670 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 4,194 | $14.00 | $58.7K | 20,739 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2016-06-02 | 2016-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-06-02 | 2016-06-06 | 128,758 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-06-02 | 2016-06-06 | 18,909 | — | $0 | 19,898 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award | 2016-06-01 | 2016-06-03 | 17,208 | $3.95 | $68.0K | 22,647 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 397 | — | $0 | 397 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 2,317 | — | $0 | 2,317 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 397 | — | $0 | 397 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 989 | — | $0 | 989 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 989 | — | $0 | 989 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 741 | — | $0 | 741 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 496 | — | $0 | 496 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 128,758 | — | $0 | 128,758 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 23,088 | $23.98 | $553.7K | 109,395 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 10,970 | $23.98 | $263.1K | 51,247 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 9,892 | — | $0 | 46,804 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 505,297 | — | $0 | 2,379,539 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 989 | — | $0 | 989 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 505,297 | — | $0 | 2,379,539 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 9,892 | — | $0 | 46,804 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 10,970 | $23.98 | $263.1K | 51,247 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 23,088 | $23.98 | $553.7K | 109,395 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 128,758 | — | $0 | 128,758 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 435 | $0.01 | $4 | 8,965 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 3,523 | $5.00 | $17.6K | 11,408 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 73,615 | $0.01 | $736 | 1,517,531 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 182,914 | $0.01 | $1.8K | 1,334,617 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 596,477 | $5.00 | $2.98M | 1,931,094 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 1,080 | $0.01 | $11 | 7,885 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2016-05-13 | 2016-05-17 | 1,941 | — | $0 | 11,391 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2016-05-13 | 2016-05-17 | 583 | — | $0 | 11,974 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2015-07-23 | 2015-07-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 548,464 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 9,386 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 21,900 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,428 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 479,714 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 16,666 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 38,888 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 18,518 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 851,852 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,800 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 25,200 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 12,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 552,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 552 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 1,296 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 577 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 27,612 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 5,465 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 12,840 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 5,715 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 273,337 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 3,271 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 7,684 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 3,420 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 163,592 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,791 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 25,226 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 11,805 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 246 | $18.00 | $4.4K | 62,217 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 131,738 | — | $0 | 131,738 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 1,296 | — | $0 | 133,034 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 551 | $18.00 | $9.9K | 132,483 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 56,379 | — | $0 | 56,379 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 552 | — | $0 | 56,931 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 235 | $18.00 | $4.2K | 56,696 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,868,959 | — | $0 | 2,868,959 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 27,612 | — | $0 | 2,896,571 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 11,736 | $18.00 | $211.2K | 2,884,835 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 61,886 | — | $0 | 61,886 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 577 | — | $0 | 62,463 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award | 2015-06-01 | 2015-06-02 | 5,438 | $12.32 | $67.0K | 5,438 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2015-05-15 | 2015-05-19 | 305 | — | $0 | 31,225 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2015-05-15 | 2015-05-19 | 1,521 | — | $0 | 30,920 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,127 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 54,163 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 136,039 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,385 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,385 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 4,459 | — | $0 | 16,329 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 778 | — | $0 | 54,941 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 136,039 | — | $0 | 136,039 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 778,272 | — | $0 | 1,263,716 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 389 | — | $0 | 56,516 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 486 | — | $0 | 56,871 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 486 | — | $0 | 56,871 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 6,952 | — | $0 | 7,812 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 972 | — | $0 | 17,301 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 60,344 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 1,126 | — | $0 | 60,344 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 59,218 | — | $0 | 59,218 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 486,420 | — | $0 | 2,041,988 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 4,345 | — | $0 | 14,764 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 9,235 | — | $0 | 31,334 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 607 | — | $0 | 11,870 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 244 | — | $0 | 38,295 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,942 | — | $0 | 38,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 488 | — | $0 | 36,331 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,950 | — | $0 | 35,843 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 1,986 | — | $0 | 11,263 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 9,235 | — | $0 | 31,334 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 4,345 | — | $0 | 14,764 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 486,420 | — | $0 | 2,041,988 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 59,218 | — | $0 | 59,218 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 1,126 | — | $0 | 60,344 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 60,344 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,950 | — | $0 | 35,843 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 488 | — | $0 | 36,331 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,942 | — | $0 | 38,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 244 | — | $0 | 38,295 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 607 | — | $0 | 11,870 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 1,986 | — | $0 | 11,263 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-17 | 2014-11-19 | 5,343 | $24.89 | $133.0K | 40,569 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-14 | 2014-11-14 | 3,928 | $25.06 | $98.4K | 45,912 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-13 | 2014-11-14 | 5,505 | $25.18 | $138.6K | 49,840 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,929 | — | $0 | 29,818 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,929 | — | $0 | 27,117 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 113,112 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 113,112 | — | $0 | 113,112 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 778,272 | — | $0 | 2,528,408 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 6,952 | — | $0 | 19,109 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 486 | — | $0 | 30,304 | SEC↗ |